By NewsDesk @infectiousdiseasenews
Local media report that Turkey is seeing an increase in Crimean-Congo hemorrhagic fever (CCHF) cases.
They report 480 cases of viral infection, including 15 fatalities.
The Scientific Council of the Turkish Ministry of Health discussed the measures to be taken before the Eid al-Adha holiday, given the increased contact with animals that threatens to increase the number of infections.
The Deputy Minister of Health, Amina Albicha said that the death rate from CCHF in other countries is 25 percent, and in some it may reach 80 percent.
She concluded by saying that the measures taken and the methods of treatment followed in Turkey resulted in reducing the death rate to 4 percent.
WHO says Crimean-Congo hemorrhagic fever is a widespread disease caused by a tick-borne virus (Nairovirus) of the Bunyaviridae family. The CCHF virus causes severe viral hemorrhagic fever outbreaks, with a case fatality rate of 10–40%
Animals become infected by the bite of infected ticks and the virus remains in their bloodstream for about one week after infection, allowing the tick-animal-tick cycle to continue when another tick bites. Although a number of tick genera are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma are the principal vector.
The CCHF virus is transmitted to people either by tick bites or through contact with infected animal blood or tissues during and immediately after slaughter. The majority of cases have occurred in people involved in the livestock industry, such as agricultural workers, slaughterhouse workers and veterinarians. Human-to-human transmission is possible.
- Brazil COVID-19 cases top 800K, 8,575 ICU beds enabled
- COVID-19: Investigational dual antibody cocktail, REGN-COV2, clinical trial initiated
- Russia COVID-19 cases top 500K, Levilimab approved for treatment
- Chagas disease vectors, kissing bugs, also find suitable climatic conditions in southern Europe
- Brazil: Mato Grosso do Sul sees worst dengue epidemic since 2014
- Disseminated Coccidioidomycosis: Reprogramming of immune system cures child